12 Sigma is an innovative healthcare company with leading artificial intelligence technology and medical imaging applications. They believe the combination of medical imaging and AI will have huge potential. It has formed partnerships with General Electric to jointly develop smart diagnosis products for tumor, cardiovascular disease and CT scan, as well as with 50 top-tier hospitals in China for applied medical diagnostics,technical research and clinical trials.

EyeArt is the first and only FDA-cleared AI technology for autonomous detection of both more than mild and vision-threatening diabetic retinopathy. The EyeArt® AI Eye Screening System is the most extensively validated autonomous AI technology, tested on over half a million patient visits globally with over two million images collected in real-world clinical environments.It is proven to be safe, fast, and consistent.